Document Detail

Soteria: Evaluation of a home-based treatment for schizophrenia.
MedLine Citation:
PMID:  238399     Owner:  NLM     Status:  MEDLINE    
Data are reported from an ongoing study comparing outcome in two groups of young, first-admission schizophrenics - one receiving "usual" treatment (including drugs) on the wards of a good community mental health center, the other being treated by a non-professional staff (usually without phenothiazines) in a small home-like facility in the community. Six-month and one-year outcome data show few differences in symptoms between the two groups, but three measures of psychosocial functioning significantly favor the experimental group.
L R Mosher; A Menn; S M Matthew
Related Documents :
1862209 - Early prediction of relapse in schizophrenia: an application of receiver operating char...
22048829 - Effects of incentive items on participation in a randomized chemoprevention trial.
3651739 - Electrodermal responding and chlorpromazine treatment in schizophrenia.
17685739 - Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients:...
8149119 - Age of onset in schizophrenia: relations to psychopathology and gender.
1754609 - Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine ...
12220799 - Course of depression, health services costs, and work productivity in an international ...
20956649 - Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
18312059 - Prenatal depression in women hospitalized for obstetric risk.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of orthopsychiatry     Volume:  45     ISSN:  0002-9432     ISO Abbreviation:  Am J Orthopsychiatry     Publication Date:  1975 Apr 
Date Detail:
Created Date:  1975-09-22     Completed Date:  1975-09-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0400640     Medline TA:  Am J Orthopsychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  455-67     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / therapeutic use
Chlorpromazine / therapeutic use
Community Mental Health Services
Costs and Cost Analysis
Evaluation Studies as Topic
Follow-Up Studies
Occupational Therapy
Patient Readmission
Professional-Patient Relations
Psychological Tests
Residence Characteristics
Residential Treatment*
Schizophrenia / drug therapy,  therapy*
Social Adjustment
Reg. No./Substance:
0/Antipsychotic Agents; 50-53-3/Chlorpromazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of 50 per cent phosphoric acid as an etching agent in orthodontics: a rational approach.
Next Document:  Mitochondrial permeability to chloride ion.